This study tested the hypothesis that limb venous responses to baroreceptor unloading are altered in individuals with high blood pressure (HBP) compared with normotensive (NT) controls. Calf venous compliance was assessed in 20 subjects with prehypertension and stage-1 hypertension (mean arterial pressure, MAP: 104 ± 1 mm Hg) and 13 NT controls (MAP: 86 ± 2 mm Hg) at baseline and during lower body negative pressure (LBNP), using venous occlusion plethysmography. Baroreflex sensitivity (BRS) was measured using the sequence technique and total peripheral resistance (TPR) was estimated from finger plethysmography. Baseline venous compliance was not different between groups, but the HBP group had lower baseline lnBRS (2.22±0.14 vs 2.7±0.18 ms mm Hg
Introduction
Reductions in venous capacitance and compliance have been suggested as potential contributors to the pathogenesis of hypertension. 1, 2 In particular, it has been proposed that attenuated venous elasticity and capacity affect blood volume redistribution in such a manner that blood volume moves from peripheral veins into small arteries 3 or centrally, 2, 4 contributing to chronic increases in arterial blood pressure (BP). Supporting this conceptual scheme, previous studies found reduced venous distensibility and blood holding capacity in animals 5, 6 and humans [7] [8] [9] with hypertension. These changes in venous circulation are potentially due to chronic increases in sympathetic autonomic regulation of venous tone. 6 In addition to chronic influences on vascular tone, the sympathetic nervous system modulates cardiovascular adjustments to short-term physiological perturbations, ensuring blood pressure homeostasis and preserving blood flow. Yet, animals and humans with hypertension often present with altered autonomic modulation and, as a result, they exhibit abnormal cardiovascular responses to short-term physiological stressors. 3, 10 Studies are inconclusive about the effects of acute sympathoexcitation on venous tone in individuals with hypertension. Using functional tests (cold pressor testing and post-handgrip exercise ischaemia), Delaney et al. 11 showed that limb venous compliance and capacitance did not respond to non-baroreflex-mediated sympathoexcitation either in normotensive (NT) or in hypertensive subjects, suggesting that the sympathetic nervous system may not be a significant modulator of limb venous tone. Others, however, reported that baroreceptor unloading, but not posthandgrip exercise ischaemia, reduced calf venous compliance in NT subjects, indicating that limb venous responses to acute sympathoexcitation may be baroreflex-mediated and are task-specific. 12 Currently, it is unknown whether baroreflex modulation of venous tone is altered in humans with hypertension.
The purpose of this study was to assess venous responsiveness to baroreceptor unloading in subjects with high BP (HBP). It was hypothesized that calf venous compliance and capacitance responses to lower body negative pressure (LBNP) would be impaired in subjects with HBP compared with agematched NT controls. Previous studies suggested that the contribution of the venous system to hypertension may be instrumental at the beginning of the hypertensive process; 1, 6, 9 thus, we studied non-medicated subjects with prehypertension and stage-1 hypertension.
Materials and methods

Subjects
A total of 20 subjects (HBP group) with prehypertension (systolic BP (SBP): 130-139 mm Hg or diastolic BP (DBP): 84-89 mm Hg) or stage-1 hypertension (SBP: 140-159 mm Hg or DBP: 90-99 mm Hg), between the ages of 35 and 55 years, participated in this study. In addition, 13 subjects with normal BP (SBP o120 mm Hg and DBP o80 mm Hg) were studied (NT group). Subject characteristics and sex distribution in each group are presented in Table 1 . Exclusion criteria included presence or history of cardiovascular, peripheral vascular, pulmonary, metabolic, neurological or kidney disease, tobacco use, a recent change in body weight (410 kg in the last 6 months) and body mass index greater than 32 kg m
À2
None of the participants were on any type of medication, including over the counter anti-inflammatory medication. Females on oral contraceptives or hormone replacement therapy and subjects who were exercising more than 2 h per week were also excluded from this study. All subjects were verbally informed about the benefits and risks of the experimental procedures and provided written informed consent before participation. All experimental protocols were approved by the Institutional Review Boards of Syracuse University (Syracuse, NY, USA) and SUNY Upstate Medical University (Syracuse, NY, USA).
Screening procedures
After review of subjects' medical and physical activity history, BP was measured on two separate occasions according to the American Heart Association guidelines. 13 Briefly, BP was measured in duplicate, in the seated position, in both arms, via the auscultatory technique after 10 min of quiet rest. At least two measurements of each arm were obtained at intervals of 2-3 min and the average of those readings was used as the subject's BP. Subjects were instructed to refrain from exercise for 24 h and to avoid caffeine and food consumption 2 h before BP screening. The overall reliability of both SBP and DBP displayed a coefficient of variation ¼ 3% and an intra-class correlation coefficient ¼ 0.95 (measurements obtained on two separate days by the same investigator).
Experimental design
After the initial BP and medical history screening, all participants performed two laboratory visits, separated by 2-7 days. All subjects were instructed to refrain from food 4 h, and alcohol, dietary supplementation, and caffeinated products at least 24 h, and any strenuous activity 12 h before testing. All female participants were tested during the first 10 days of their menstrual cycle.
On visit 1, all subjects were familiarized with the venous compliance measurements and the pressure chamber. In addition, they performed a graded exercise test on a cycle-ergometer and underwent a body composition test (% body fat) using air displacement plethysmography (BodPod, Life Measurement, Concord, CA, USA). Calf volume and resting stroke volume (SV) were also measured. On visit 2, venous compliance was measured at baseline and during application of LBNP. To avoid the effects of hypovolemia on sympathetic outflow, 14 all subjects were instructed to consume 250 ml of water every hour, beginning B6 h before sleep the night before, and continuing during the morning of the second visit (LBNP testing). 15 Graded exercise testing Aerobic capacity was assessed using a customized cycling protocol. Briefly, intensity started at 25 W for females and 50 W for males for 2 min and increased by 25 W every 2 min, until volitional fatigue was reached. Throughout the test, expired gases were analysed using a calibrated breath-by-breath metabolic system (Quark b 2 , COSMED, Rome, Italy). 16 Peak oxygen consumption (VO 2 peak) was used as an index of aerobic capacity. Effort was considered maximum when subjects met three of the following criteria: (1) a final rating of perceived exertion score X17 (Borg scale: 1-20), (2) respiratory exchange ratio X1.15, (3) a maximum heart rate (HR) ¼ age-predicted maximum HR ± 10 b.p.m. and (4) change in oxygen uptake (VO 2 ) o150 ml with an increase in workload. 16 Calf volume Anthropometric measures were used to calculate calf volume as described previously. 17 Briefly, calf volume was calculated using the formula: Calf volume ¼ pr 2 * L, where L is one calf segment length and r is the mean radius. The mean radius was calculated from the average of four girth measures, obtained equidistantly between the medial malleolus and the tibial plateau. The results of this method have been shown to be strongly correlated (r ¼ 0.94) with direct volumetric displacement. 17 Venous occlusion plethysmography Subjects were tested in the supine position with the right leg supported at the thigh and ankle and placed above heart level to promote venous drainage. A venous collecting cuff was placed B5 cm proximal to the knee on the right leg and connected to a rapid cuff inflator (model E20, DE Hokanson, Bellevue, WA, USA), which was attached to an external air source (model AG101, DE Hokanson). A mercury-in-Silastic strain gauge (model EC6, DE Hokanson) was placed around the right calf at the point of maximum girth. The strain gauge was electronically calibrated before testing.
Whole-limb venous compliance was estimated non-invasively, using the technique developed by Robinson et al. 18 as modified by Halliwill et al.
19
The venous collecting cuff was inflated to 60 mm Hg for 8 min. 19 After the 8 min-inflation period, the collecting cuff pressure was reduced at a rate of 1 mm Hg sec À1 (over 1 min) to 0 mm Hg, using an automatic stepper motor (DE Hokanson). This rate of cuff deflation was chosen based on the evidence that intravenous pressure tracks collecting cuff pressure, when cuff pressure drops at a rate of B1 mm Hg sec À1 . 19, 20 During the deflation period, changes in limb volume measured by the strain gauge and the drop in collection pressure were recorded and used to create the volume-pressure curves. Cuff pressure was used as a surrogate of intravenous pressure. 19 Previous studies have determined the relationship between collecting cuff pressure and intravenous pressure in young (r ¼ 0.998) and older NT adults (r ¼ 0.999), 20 as well as in hypertensive subjects (r ¼ 0.998). 11 In our laboratory, the coefficient of variation of this method is o10% (measurements obtained on two separate days in a sample of 14 subjects). Data were collected at a rate of 200 Hz via a data acquisition system (BIOPAC, Santa Barbara, CA, USA). Venous compliance was measured at resting conditions (baseline) and during LBNP. There was a 20-min resting period between trials. Previous studies have shown that this time period is sufficient to allow for reproducible measurements of limb venous compliance in humans. 20 LBNP testing. Subjects were in the supine position enclosed in a one-legged chamber, up to the level of the umbilicus. LBNP (À50 mm Hg) was applied only to the left leg and pelvis for the entire inflation and deflation venous compliance protocol. 12 Negative pressure was induced using a commercially available vacuum and was continuously monitored with a digital differential manometer (model 840 080, SPER Scientific, Scottsdale, AZ, USA) to ensure that the desired pressure was maintained.
Beat-to-beat hemodynamic measurements At 3 min before and throughout all venous compliance measurements, beat-to-beat arterial pressure was measured using finger plethysmography (Finometer, Finapres Medical Systems, Amsterdam, The Netherlands). SBP, DBP, mean arterial pressure (MAP) and HR were derived from the arterial pressure waveform. The arterial pulse wave contour method was used to calculate SV changes during LBNP. 21 The baseline SV values obtained via the Finometer (Finapres Medical Systems) were adjusted to the SV values obtained by ultrasound procedures (see below). A correction factor was calculated (correction factor ¼ SV ultrasound /SV Finometer ), which was applied to all SV measurements obtained from the Finometer (Finapres Medical Systems) during LBNP. Cardiac output was calculated as the product of HR and SV, and cardiac index was expressed as ml min À1 m À2 by correcting for body surface area. Total peripheral resistance (TPR, dyn sec À1 cm À5 m 2 ) was calculated from the formula: (MAP/cardiac index) * 80.
Echocardiography
Echocardiographic assessment of the parasternal long-axis view was performed using 2-dimensional, real-time imaging, complimented by additional M-mode (motion mode) modality. A 15 mm broadband (4 MHz) transducer was used to identify left ventricular structures. Left ventricular systolic (LVESV) and diastolic volumes (LVEDV) were determined (Sonosite, Bothell, WA, USA) and SV was calculated as follows: SV ¼ LVEDV-LVESV. SV was measured three times and the average of the measurements was recorded. All SV measurements were perfomed by the same investigator. In our laboratory, the coefficient of variation (%) for ultrasound measurements performed on two separate days is o6%.
Data analyses
Determination of venous compliance. Venous compliance was determined from the volume-pressure curves generated from the volume-pressure relationship, as pressure was decreased from 60 mm Hg to 10 mm Hg at a rate of 1 mm Hg sec À1 . 19 Data below 10 mm Hg were excluded, because they violate the assumption that collecting cuff pressure is a surrogate of intravenous pressure. 19 Individual volumes measured during the deflation period were binned into 2 mm Hg increments for each task (SPSS version 16, SPSS, Chicago, IL, USA). These data were plotted against pressure, creating a volumepressure curve for each individual. This curve was compared by means of the quadratic equation:
2 . For this model, DCalf volume was equal to calf volume at a given pressure minus calf volume before cuff inflation. Calf volume across pressures from 60 to 10 mm Hg was used as an index of calf venous capacitance, assuming that cuff pressure is an index of transmural distending pressure. 11 As the pressure-volume relationship is nonlinear, a single number cannot be used to define the slope of the pressure-volume curve. Therefore, the group-average regression parameters b 1 and b 2 were used to estimate venous compliance as follows: Compliance ¼ b 1 þ 2* b 2 *(cuff pressure). 19 Compliance was then plotted against pressures from 60 to 10 mm Hg and the compliance-pressure relationship was evaluated graphically. Baroreflex sensitivity (BRS) and blood pressure variability. SBP variability was calculated using the WinCPRS software (Absolute Aliens Oy, Turku, Finland) from the systolic arterial pressure waveform collected via finger plethysmography (Finometer, Finapres Medical Systems). These procedures have been described in detail elsewhere. 22 Briefly, the spectrum of the non-equidistant waveform of the SBP time-series was calculated using fast Fourier transformation and the spectral power at low frequency ranges (LF SBP : 0.05-0.15 Hz) was used as an index of sympathetic modulation of vasomotor tone. 23 Spontaneous BRS was determined from the coupling between fluctuations in R-R intervals and SBP, using the sequence technique as previously described. 22 Briefly, the slope of the regression line between SBP and R-R intervals that changed in the same direction for three or more consecutive beats for at least 4 ms was used to calculate BRS (ms mm Hg À1 ). 22 In our laboratory, the coefficient of variation of BRS measurements using the sequence technique is o14% (measurements obtained on two separate days in a sample of 32 subjects).
Statistical analysis
Independent t-test was used to examine group differences in subject baseline characteristics. The indexes of BP variability and BRS were not normally distributed and thus, statistics on these measures were performed after logarithmic transformation (ln). A mixed-model repeated-measures analysis of variance was used to determine the effects of group (HBP vs NT) and condition (baseline vs LBNP) on the regression parameters (b o , b 1 , b 2) , and the hemodynamic, BP variability and BRS responses. A mixed-model repeated-measures ANOVA was also used to assess the effects of group and condition on calf volume across pressures from 60 to 10 mm Hg. If significant interactions were detected, post hoc analysis with a Bonferroni correction was performed. Pearson's correlation coefficients were calculated to examine the relationship between baseline calf venous compliance (at venous pressures of 20 and 50 mm Hg) and change in calf venous compliance in response to LBNP. The significance level of all statistical analyses was set at a ¼ 0.05 and all data are reported as means±s.e.
Results
Subject characteristics
There were no group (HBP vs NT) differences in age, height, weight, % body fat, VO 2 peak, calf volume, resting HR, resting cardiac index and stroke index (P40.05, Table 1 ). By study design, subjects in the HBP group had greater SBP, DBP and MAP, than the NT group (Table 1) , Po0.001. In addition, the HBP group had greater resting TPR compared with the NT group (Table 1) , Po0.01. Further, there were no differences in resting lnLF SBP (Figure 1a) between groups (P40.05), but the HBP group had lower 
Po0.05 vs NT).
Baroreceptor unloading and venous function S Goulopoulou et al baseline cardiovagal lnBRS (Figure 1b) , Po0.05. Within the HBP group, there were eight subjects with prehypertension (6m/2f; SBP: 127 ± 2 mm Hg, DBP: 86±1 mm Hg) and 12 subjects with stage-1 hypertension (8m/4f; SBP: 133±1 mm Hg, DBP: 94 ± 1 mm Hg). There were no significant differences in any of the descriptive characteristics, other than the BP levels between the subjects with prehypertension and those with stage-1 hypertension (P40.05). Table 2 illustrates that there were no significant differences in baseline regression parameters b o , b 1 and b 2 between the HBP group and the NT group (P40.05), suggesting that there were no group differences in baseline venous compliance. In addition, baseline calf volume across all pressures was similar between groups (P40.05), indicating no group differences in baseline venous capacitance (Figure 2a and b) .
Baseline calf venous compliance
Calf venous compliance, hemodynamic and BRS responses to LBNP Changes (D) in hemodynamic variables from baseline (supine rest) to LBNP (last 2 min) are presented in Table 3 . MAP, DBP and HR measured during LBNP were greater than baseline values in both groups (Po0.05). SBP during LBNP was not different from baseline in any of the groups (P40.05), whereas stroke index and cardiac index were reduced (Po0.05) in response to LBNP, similarly in both groups. TPR increased in both groups during LBNP, but the magnitude of this increase was greater in the HBP group (Po0.05).
Application of LBNP reduced the slope of the volume-pressure curve only in the NT group as indicated by a reduction in the regression parameters b 1 and b 2 (Po0.05), suggesting that LBNP decreased calf venous compliance only in NT controls (Table 2 and Figures 2c and d) . In addition, calf volume across all pressures (Figure 2a (Figure 1a ) and reduced spontaneous lnBRS (Figure 1b) , Po0.05. There were no group differences in the magnitude of change in lnLF SBP during LBNP, but the NT group showed a greater reduction in lnBRS compared with HBP during task (Po0.05).
The change in calf venous compliance at 20 mm Hg during LBNP was positively correlated with baseline calf venous compliance at 20 mm Hg in the overall population (r ¼ 0.797, Po0.001), the HBP group (r ¼ 0.839, Po0.001) and the NT group (r ¼ 0.824, Po0.01). The change in calf venous compliance at 50 mm Hg during LBNP was positively correlated with baseline calf venous compliance at 50 mm Hg in the overall population (r ¼ 0.740, Po0.001), the HBP group (r ¼ 0.778, Po0.001), but not in the NT group (P40.05).
Discussion
The main findings of this study demonstrated that subjects with HBP had attenuated venous compliance and capacitance responses, and augmented peripheral vascular resistance responses to LBNP, when compared with NT controls. To the best of our knowledge, this is the first study to show that venous responses to baroreceptor unloading are altered in humans with prehypertension and stage-1 hypertension.
Application of LBNP results in central hypovolemia, which challenges the baroreceptor and cardiopulmonary volume receptor function. 24 Specifically, LBNP induces blood volume translocation from the upper body to the lower extremities, accompanied by a transient reduction in arterial pressure and reflex increases in endogenous adrenergic activity. 25 The blunted venous capacitance/compliance response to a hypovolemic stress, noted in the HBP group, could be indicative of any of the following physiological adaptations: (a) attenuated baroreflex control of peripheral venomotor tone, (b) chronically reduced venous capacitance, (c) reduced sympathetic outflow during LBNP due to an impaired baroreflex or (d) reduced venous sensitivity to sympathoexcitation due to elevated basal sympathetic activity.
Earlier studies have shown that the baroreceptor reflex system dominates the regulation of the venous circulation. 26, 27 Chronically elevated BP may alter the compliance of the cardiopulmonary walls, where the volume receptors are situated, reducing the sensitivity of the baroreceptors and altering baroreflex-mediated sympathetic regulation of the circulation. In this study, we tested the hypothesis that subjects with HBP would have impaired venous responses to baroreceptor unloading. Indeed, the HBP group had reduced venous responsiveness to LBNP. Furthermore, our findings show reducedbaseline cardiovagal BRS at baseline and in response to LBNP in the HBP group, suggesting that changes in baroreflex function occur early on in the hypertensive process. Previous studies reported that both animals and humans with hypertension had impaired baroreceptor control of the cardiovascular system; 28 however, this impairment was not homogenous. 29 In fact, hypertensive rabbits had reduced baroreflex control of HR, whereas baroreflex control of peripheral vascular resistance was unmodified or enhanced. 30 Subsequent studies in humans with moderate and severe hypertension confirmed the differential baroreceptor modulation of the arterial system. 31 Whether chronically elevated BP is related with differential influences upon baroreflex modulation of vasomotor and venomotor tone has not been elucidated and warrants further research.
Reduced baseline venous capacitance in the HBP group could also explain their blunted venous response to LBNP. Specifically, a chronic decline in baseline venous capacitance in this group would lead to less blood volume translocation from the upper body to the lower extremities during LBNP and consequently, less stimulation of the baroreceptors and cardiopulmonary receptors. In other words, the magnitude of the stimulus upon the pressure and volume receptors would be smaller in subjects with reduced venous blood holding capacity and therefore, reflex sympathetic activity would be diminished. In the present study, however, the subjects with elevated and normal BP had similar changes in central blood volumes during LBNP, suggesting similar central blood volume translocation during LBNP between groups. In addition, baseline volume across pressures from 10 to 60 mm Hg (index of venous capacitance) did not differ between groups, suggesting that the subjects with high BP did not have reduced baseline venous capacitance compared with the NT group.
Reduced venous sensitivity to sympathetic stimulation may also contribute to the lack of change in venous compliance and capacitance during LBNP in the HBP group. It has been postulated that as resting sympathetic outflow is high in individuals with HBP, acute increases in sympathetic activity cannot further reduce venous capacitance. 11 Calf venous vessels can be influenced by sympathetic stimulation either through direct neural innervation or indirectly through circulating norepinephrine actions. 12 In this study, analysis of BP variability was used to estimate sympathetic modulation of vasomotor tone. 23 According to this analysis, there were no group differences in baseline sympathetic modulation of vasomotor tone, and LBNP induced similar increases in peripheral sympathetic modulation in HBP and NT groups. However, a relationship between LF SBP and sympathetic modulation of venous tone has not been previously reported. LF SBP was used in the present study to confirm increases in LBNP-induced peripheral sympathetic activity. Future studies providing direct measures of peripheral sympathetic nervous system activity are necessary to delineate the effects of hypertension on sympathetic modulation of venous tone in humans.
In addition to functional changes of the venous system, structural alterations of the venous wall could contribute to attenuated venous responsiveness. In the present study, the correlation analyses revealed two interesting characteristics. First, changes in venous compliance at low pressures (that is, 20 mm Hg) during LBNP were positively correlated with baseline venous compliance at 20 mm Hg in both groups, indicating that individuals with greater baseline venous compliance show greater reductions in venous compliance during baroreceptor unloading. When venous compliance was calculated at 50 mm Hg, the relationship between baseline venous compliance and changes in venous compliance during LBNP was significant only in the HBP group. It has been suggested that at higher pressures, collagen fibers in the venous wall are recruited to restrict further pooling in the legs, 32, 33 whereas at low pressures, the expansion of the veins involve no actual stretch of elastic material in their walls. 33 A relationship between the structural components of the vessel walls and the vascular resistance responses during vascular smooth muscle contraction has been previously reported. 9 Thus, it is possible that alterations in the venous wall of humans with HBP also affect capacitance and compliance responses to sympathetic stimulation, and this effect is greater at higher pressures (that is, during standing). Indeed, animal studies show that hypertension is accompanied by vascular wall remodelling and changes in the composition of the wall components. 34, 35 Furthermore, hypertensive patients often present with exaggerated postural hypotension. 29 Taken together, these findings suggest that structural modifications of the venous wall may contribute to a blunted venous response to baroreceptor unloading.
Although venous compliance and capacitance did not change in response to LBNP, TPR showed an exaggerated response to this stimulus in the HBP group, indicating greater vasoconstrictor response compared with NT controls during baroreceptor unloading. These findings are in agreement with previous investigations reporting that the increase in vascular resistance in response to head-up tilt was amplified in hypertensive subjects compared with NTs, and was positively correlated with age and baseline values. 36 The exaggerated vascular resistance response to head-up tilt in hypertension has not been explained by a greater sympathetic response. 37 Thus, mechanisms other than autonomic neural regulation should be taken into consideration. London et al. 36 suggested that vascular wall hypertrophy might amplify the vascular resistance responses to head-up tilt. In addition, hormonal responses to central hypovolemia could induce different vascular resistance responses.
A few limitations deserve mention. Despite being appropriately powered, this study included a small sample size and therefore, caution is needed when the results are extrapolated to the general population. Further, the effect of gender was not examined in this study. Monahan et al.
12 demonstrated a gender effect on venous compliance responses to LBNP, with males responding to LBNP with a 25% reduction in venous compliance, whereas females were not responsive to this task. In the present study, there were a larger number of females in the NT group. If gender had considerably influenced our results, the larger number of females in the NT group should have contributed to a failure to detect a reduction in venous compliance during LBNP. On the other hand, the larger number of males in the HBP group should have enhanced our ability to detect responses to LBNP; but this was not the case. Yet, the effect of gender on venous compliance in subjects with HBP warrants further investigation. Although according to medical history questionnaires none of the subjects had been diagnosed with any metabolic disorder or was on any type of medication, blood samples were not collected to assess confounding metabolic abnormalities (for example, diabetes, hyperlipidemia). In addition, ambulatory BP data were not collected in this study and, therefore, we cannot rule out the presence of masked hypertension in the control group or white-coat hypertension in the HBP group. Yet, our screening procedures included multiple measurements and were performed according to the American Heart Association guidelines. With regards to the methodology employed in this study, it should be recognized that strain-gauge venous occlusion plethysmography measures wholelimb venous compliance, and therefore, measurements may be impacted by compliance of all the other tissues that the strain gauge surrounds.
Perspectives. In the present study, the subjects with prehypertension and stage-1 hypertension did not have reduced calf venous compliance and capacitance at baseline. Nevertheless, they showed reduced venous responsiveness to LBNP, suggesting that resting measurements of venous function may not adequately reflect alterations in venous tone, which occur early on in the hypertensive process. Further, it has been proposed that reduced-venous compliance and capacitance contribute to blood volume redistribution from peripheral veins to the cardiopulmonary compartment, increasing cardiac output and leading to chronic increases in BP. 1, 4, 6, 9 On the contrary, our subjects with HBP had normal cardiac output, which suggests that early hypertension may not be a hyperkinetic stage in all clinical cases. Indeed, only 50% of cases with hypertension presents with elevated cardiac output. 38 Given that cardiac output was not elevated and baseline compliance and capacitance were not reduced, but venous responsiveness to baroreceptor unloading was impaired in the HBP group, one can speculate that the link between hypertension and the venous system is not limited to the role of the venous tone in blood volume redistribution and centralization. The blunted venous response to baroreceptor unloading may be a compensatory mechanism to counteract the exaggerated vascular resistance response in the HBP group, serving as a protective mechanism to inhibit further increases in BP. Whether and how this adaptive physiological response is altered with the progression of hypertension is currently unknown. Further, investigating the differential impact of anti-hypertensive therapies on the arterial and venous circulations warrants further research.
In conclusion, the present study provides evidence for attenuated venous and augmented vascular resistance responsiveness to LBNP in subjects with prehypertension and stage-1 hypertension. The blunted venous compliance and capacitance response may be a compensatory mechanism to counteract the elevated vascular resistance and protect from further increases in BP during acute sympathoexcitation. These vascular adaptations occur at the early stages of hypertension and in the absence of alterations in baseline measures.
